From first-hand experience, members of our Pharmaceutical Group understand the importance of patents, trademarks, and trade secrets to pharmaceutical companies. Group members have conducted research at and represented pharmaceutical giants and start-ups alike. This means we understand the interaction of patents with a range of FDA issues such as patent term extensions, non-patent exclusivities, Orange Book listing requirements, Hatch-Waxman issues, and ANDA (Abbreviated New Drug Application) litigation.
"In addition to the hands-on prosecution and portfolio, they also provide more strategic advice regarding positioning portfolios, dealing with partners and helping us get to a dominant position in our field so that we would be a beneficial partner to another entity."
Our attorneys also are experienced in handling a wide variety of licensing issues and work with our clients to license in as well as license out technology.
"They want to get to the bottom of an issue and help a client get the maximum value out of the science."
Clients include global and emerging pharmaceutical companies, such as Shire and Progenics Pharmaceuticals as well as prestigious academic and research institutions such as Harvard Medical School, Dana Farber Cancer Institute, and Sloan-Kettering. They appreciate our depth of experience as well as our attention to client service.
"On a service level, they are at the top of the list. They are timely, clear communicators and the eye for detail is very, very good."